2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
The 2025 guideline is developed by a multidisciplinary Task Force and is an update from the 2018 ESC Guidelines on cardiovascular disease during pregnancy. The new 2025 guideline adds important new information and evidence, update risk-scoring and new chapters on e.g. the organisation and tasks of the Pregnancy Heart Team, updated and new disease specific chapters and a dedicated chapter on long term effects of adverse pregnancy outcomes.
Copyright permission
Guidelines and related materials are for use by individuals for personal or educational purposes. No commercial use is allowed. Re-use permission must be correctly obtained from the publisher ESC Guidelines are protected by copyright. As per opt out option under Article 4 §3 of EU Directive 2019/790, the ESC reserves all rights to license uses of ESC Guidelines to train or develop generative artificial intelligence (AI) models, large language models or other deep learning or machine learning models. Any use of ESC Guidelines in software tools, generative AI models, computational models, or algorithms in which ESC Guideline content is included, cited, or transformed in any way requires a formal license agreement.
ESC Chat - Your Guidelines Companion
ESC Chat provides instant and personalised answers to clinical queries, based exclusively on current ESC Clinical Practice Guidelines.
Educational material
The Pregnancy Heart Team unveiled in the 2025 ESC Guidelines: who is in, who benefits, and how to deliver
2025 ESC Guidelines on Cardiovascular Disease and Pregnancy: management of heart failure and arrhythmias
2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy
Tools
Slide Set
Educational material.
Patient versions of ESC Guidelines
ESC Patient Guidelines translate expert clinical recommendations into clear, everyday language.
ESC Pocket Guidelines Mobile App
Convenient resources available directly on your mobile device.
